MALCISBO
Malcisbo develops novel carbohydrate-based vaccines for human and animal health. Their focus is on parasitic diseases, on human food safety and on zoonotic diseases. The company has developed its proprietary target discovery platform to identify carbohydrates as vaccine targets. Combined with their glycoengineering technologies, novel and efficient glycoconjugate vaccines are being developed. Malcisbo is developing a strong pipeline of novel vaccine products coming out this platform for unmet needs in human and veterinary medicine targeting large markets. It is Malcisbo’s goal to develop affordable vaccines to protect people in underdeveloped areas against parasitic worm infections (e.g., helminthic infections by hookworm, filaria or schistosoma).
MALCISBO
Industry:
Biotechnology Health Care Medical Test And Measurement
Founded:
2010-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.malcisbo.com
Total Employee:
1+
Status:
Active
Contact:
41 44 633 78 87
Email Addresses:
[email protected]
Total Funding:
130 K CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Mobile Non Scaleable Content Nginx Euro JsDelivr
Similar Organizations
Canostix
Canostix is developing a multi-cancer screening blood test that combines photonics and machine learning.
VLPbio
VLPbio focuses on research and development of chimeric virus like particles (VLPs) as vaccines in animal and human health.
Wellcome Trust
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health.
Investors List
Venture Kick
Venture Kick investment in Pre Seed Round - Malcisbo
Venture Kick
Venture Kick investment in Grant - Malcisbo
Official Site Inspections
http://www.malcisbo.com
- Host name: rlx2.loginserver.ch
- IP address: 116.202.48.150
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Malcisbo"
About us - Malcisbo
The main focus of Malcisbo’s platform is on bacterial diseases targeting animal health, human food safety and zoonotic diseases. Our first vaccines target human Campylobacter infections …See details»
Malcisbo
Based on a novel glycoengineering platform, we develop vaccines with a current focus on farming animals. Our first projects target colonization in chicken and Actinobacillus pleuropneumonie infection in pigs.See details»
Malcisbo - Crunchbase Company Profile & Funding
Malcisbo develops novel carbohydrate-based vaccines for human and animal health. Their focus is on parasitic diseases, on human food safety and on …See details»
Malcisbo Company Profile 2024: Valuation, Funding
Developer of carbohydrate-based vaccines designed to target bacterial diseases targeting animal health, human food safety, and zoonotic diseases. The …See details»
Malcisbo AG Company Profile | Schlieren, ZÜRICH, Switzerland ...
Find company research, competitor information, contact details & financial data for Malcisbo AG of Schlieren, ZÜRICH. Get the latest business insights from Dun & Bradstreet.See details»
Malcisbo Company Profile - Office Locations, Competitors ... - Craft
Malcisbo is a company specializing in glycoengineering technologies to develop novel and efficient glycoconjugate vaccines. It offers vaccines for Campylobacter, food poisoning agents, …See details»
Technologies & Projects - Malcisbo
Malcisbo’s mission is to reduce antibiotic treatment in the farming animal sectors to prevent further arising antibiotic resistances. Therefore, novel anti – bacterial vaccines need to be …See details»
Malcisbo - Products, Competitors, Financials, Employees, …
Malcisbo is a biotechnology company focused on the development of carbohydrate-based vaccines for the agricultural sector. Use the CB Insights Platform to explore Malcisbo's full profile.See details»
Malcisbo - Overview, News & Similar companies | ZoomInfo.com
View Malcisbo (www.malcisbo.com) location in Zurich, Switzerland , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Malcisbo AG - startup.ch
Malcisbo AG: The startup develops vaccines on the basis of carbohydrates (sugars) to fight parasites such as the red stomach worm Haemonchus contortus of sheep and goats. The …See details»
Malcisbo AG | VentureRadar
Website: http://www.malcisbo.com/ Develops glycoengineering technologies for novel glycoconjugate vaccines, targeting bacterial diseases in animals, reducing human exposure, …See details»
Malcisbo AG - startup.ch
Malcisbo AG Platform to identify carbohydrate targets in pathogenic organisms. Website: www.malcisbo.com. Headquarter: Schlieren Foundation Date: June 2010See details»
Malcisbo - Crunchbase
Malcisbo develops novel carbohydrate-based vaccines for human & animal health.See details»
Investors - Malcisbo
Private investors own the majority of Malcisbo AG. Further investors are the ZKB & ETH. Our shareholders receive quarterly detailed reporting about the company’s progress.See details»
Malcisbo AG - top100startup.ch
Sep 19, 2011 · Malcisbo AG: The startup develops vaccines on the basis of carbohydrates (sugars) to fight parasites such as the red stomach worm Haemonchus contortus of sheep and …See details»
Malcisbo Ag - Schlieren 8952 (Bezirk Dietikon), Wagistrasse
Die Gesellschaft bezweckt die Erforschung, Entdeckung, Entwicklung, Herstellung und Vermarktung von pharmazeutischen Wirkstoffen sowie anderen medizinischen oder …See details»
Malcisbo - Contacts, Employees, Board Members, Advisors & Alumni
Malcisbo develops novel carbohydrate-based vaccines for human & animal health.See details»
Careers - Malcisbo
Malcisbo is a biopharmaceutical company that develops carbohydrate-based vaccines. Our laboratories and offices are based in the Biotechnopark in Schlieren, Switzerland. Malcisbo is …See details»
Malcisbo AG - VentureRadar
"Malcisbo owns a proprietary target discovery platform which it uses in combination with glycoengineering technologies to design novel and efficient carbohydrate based vaccines.See details»
News - malcisbo.com
Ranked #47 in the Top100 in Switzerland - Malcisbo was ranked in the Top100 of Swiss Start-up companies. Researchers at the ETH Zurich have isolated a protein from a fungus which …See details»